NASDAQ Healthcare Medical - Diagnostics & Research SHC

Sotera Health Company

$ 15.82 2.33 %

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.

CEO: Michael Petras Jr. - https://soterahealth.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

$21.5 35.90 %

Recommandation

Buy

DCF

$ -1.59

Loading data...

SHC vs S&P500

Loading data...

No data available.

Quick ratio

2.52

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

38.59

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.41

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

20.57 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

7.96 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

9.85

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

3.65

means it relies more on debt, which can increase financial risk.

Free cash flow per share

0.33

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
1.69 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
1.52 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.70 indicates a moderate level of debt, which is generally acceptable but may present some risk
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.